Treating to Target for Patients With Hypertension
This study has been completed.
Sponsor:
University of California, San Francisco
Collaborator:
Kaiser Permanente
Information provided by (Responsible Party):
Thomas Bodenheimer, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01013857
First received: November 12, 2009
Last updated: November 9, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients with poorly controlled hypertension will have improved hypertensive control with telephone coaching and with telephone coaching combined with home-titration of medications.
| Condition | Intervention |
|---|---|
|
Hypertension |
Behavioral: Health coaching Behavioral: Health coaching plus home titration |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Treating to Target for Patients With Hypertension |
Resource links provided by NLM:
Further study details as provided by University of California, San Francisco:
Primary Outcome Measures:
- Systolic blood pressure [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Diastolic blood pressure [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Enrollment: | 240 |
| Study Start Date: | January 2009 |
| Study Completion Date: | December 2011 |
| Primary Completion Date: | February 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Health coaching
Phone patients every week to discuss medication adherence
|
Behavioral: Health coaching
Calling patients every week to discuss medication adherence
|
|
Experimental: Health coaching plus home-titration
Health coaches call patients every week to discuss medication adherence and to intensify medications if appropriate according to physician-created algorithm
|
Behavioral: Health coaching plus home titration
Calling patients every week and intensifying medications if appropriate based on physician-created algorithm
|
Detailed Description:
Patients with poorly controlled hypertension are randomized to a control arm which receives telephone coaching or an active arm which receives telephone coaching plus intensification of medications via telephone coaching with the coaches using treatment algorithms approved by the patients' physician. These patients' blood pressure control will be compared with usual care patients in a passive arm (chart review only).
Eligibility| Ages Eligible for Study: | 30 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- 2 blood pressure readings above 145/90.
Exclusion Criteria:
- Cognitive impairment,
- Short life expectancy,
- Creatinine greater than 1.5,
- Inability to check blood pressures at home.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01013857
Locations
| United States, California | |
| San Francisco General Hospital | |
| San Francisco, California, United States, 94110 | |
Sponsors and Collaborators
University of California, San Francisco
Kaiser Permanente
Investigators
| Principal Investigator: | Thomas Bodenheimer, MD | University of California, San Francisco |
More Information
No publications provided by University of California, San Francisco
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Thomas Bodenheimer, Adjunct Professor, University of California, San Francisco |
| ClinicalTrials.gov Identifier: | NCT01013857 History of Changes |
| Other Study ID Numbers: | H40013-33128-02 |
| Study First Received: | November 12, 2009 |
| Last Updated: | November 9, 2012 |
| Health Authority: | United States: Institutional Review Board |
Additional relevant MeSH terms:
|
Hypertension Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 19, 2013